BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33256871)

  • 1. Systematic review and meta-analysis on the role of mitochondrial cytochrome c oxidase in Alzheimer's disease.
    Morais FM; Ribeiro AM; Moreira FA; Silva PVG
    Acta Neuropsychiatr; 2021 Apr; 33(2):55-64. PubMed ID: 33256871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome c oxidase in Alzheimer's disease brain: purification and characterization.
    Parker WD; Parks JK
    Neurology; 1995 Mar; 45(3 Pt 1):482-6. PubMed ID: 7898701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electron transport chain defects in Alzheimer's disease brain.
    Parker WD; Parks J; Filley CM; Kleinschmidt-DeMasters BK
    Neurology; 1994 Jun; 44(6):1090-6. PubMed ID: 8208407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of acupuncture and moxibustion on energy metabolism-related protein of hippocampal neuron mitochondria in Alzheimer's disease rats].
    Luo L; Sun GJ; Du YJ
    Zhongguo Zhen Jiu; 2013 Oct; 33(10):913-8. PubMed ID: 24377225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling the role of metal ions and low catalytic activity of cytochrome C oxidase in Alzheimer's disease.
    Alleyne T; Mohan N; Joseph J; Adogwa A
    J Mol Neurosci; 2011 Mar; 43(3):284-9. PubMed ID: 20725867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facilitation of brain mitochondrial activity by 5-aminolevulinic acid in a mouse model of Alzheimer's disease.
    Omori C; Motodate R; Shiraki Y; Chiba K; Sobu Y; Kimura A; Nakaya T; Kondo H; Kurumiya S; Tanaka T; Yamamoto K; Nakajima M; Suzuki T; Hata S
    Nutr Neurosci; 2017 Nov; 20(9):538-546. PubMed ID: 27329428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome c oxidase in Alzheimer's disease.
    Maurer I; Zierz S; Möller HJ; Jerusalem F
    Neurology; 1995 Jul; 45(7):1423. PubMed ID: 7617212
    [No Abstract]   [Full Text] [Related]  

  • 8. Mitochondria in Alzheimer's disease.
    Swerdlow RH; Kish SJ
    Int Rev Neurobiol; 2002; 53():341-85. PubMed ID: 12512346
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet cytochrome oxidase and citrate synthase activities in APOE ε4 carrier and non-carrier Alzheimer's disease patients.
    Wilkins HM; Koppel SJ; Bothwell R; Mahnken J; Burns JM; Swerdlow RH
    Redox Biol; 2017 Aug; 12():828-832. PubMed ID: 28448944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome oxidase deficiency in Alzheimer's disease.
    Parker WD; Filley CM; Parks JK
    Neurology; 1990 Aug; 40(8):1302-3. PubMed ID: 2166249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cytochrome c oxidase deficient hippocampal neurones in Alzheimer's disease.
    Cottrell DA; Borthwick GM; Johnson MA; Ince PG; Turnbull DM
    Neuropathol Appl Neurobiol; 2002 Oct; 28(5):390-6. PubMed ID: 12366820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease.
    Mosconi L; de Leon M; Murray J; E L; Lu J; Javier E; McHugh P; Swerdlow RH
    J Alzheimers Dis; 2011; 27(3):483-90. PubMed ID: 21841246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Mitochondrial Biomarker-Based Study of S-Equol in Alzheimer's Disease Subjects: Results of a Single-Arm, Pilot Trial.
    Wilkins HM; Mahnken JD; Welch P; Bothwell R; Koppel S; Jackson RL; Burns JM; Swerdlow RH
    J Alzheimers Dis; 2017; 59(1):291-300. PubMed ID: 28598847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysfunction of mitochondria and oxidative stress in the pathogenesis of Alzheimer's disease: on defects in the cytochrome c oxidase complex and aldehyde detoxification.
    Ohta S; Ohsawa I
    J Alzheimers Dis; 2006 Jul; 9(2):155-66. PubMed ID: 16873963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced platelet cytochrome c oxidase activity in Alzheimer's disease.
    Parker WD; Mahr NJ; Filley CM; Parks JK; Hughes D; Young DA; Cullum CM
    Neurology; 1994 Jun; 44(6):1086-90. PubMed ID: 8208406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial enzyme expression in the hippocampus in relation to Alzheimer-type pathology.
    Nagy Z; Esiri MM; LeGris M; Matthews PM
    Acta Neuropathol; 1999 Apr; 97(4):346-54. PubMed ID: 10208273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortical cytochrome oxidase activity is reduced in Alzheimer's disease.
    Mutisya EM; Bowling AC; Beal MF
    J Neurochem; 1994 Dec; 63(6):2179-84. PubMed ID: 7964738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased proteolytic activity of the mitochondrial amyloid-β degrading enzyme, PreP peptidasome, in Alzheimer's disease brain mitochondria.
    Alikhani N; Guo L; Yan S; Du H; Pinho CM; Chen JX; Glaser E; Yan SS
    J Alzheimers Dis; 2011; 27(1):75-87. PubMed ID: 21750375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dystrophic neurites of senile plaques in Alzheimer's disease are deficient in cytochrome c oxidase.
    Pérez-Gracia E; Torrejón-Escribano B; Ferrer I
    Acta Neuropathol; 2008 Sep; 116(3):261-8. PubMed ID: 18629521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
    Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
    Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.